Reduce radiation dose and obtain images of the same quality as before

Samsung Electronics has received U.S. Food and Drug Administration (FDA) approval for its premium digital X-ray GC85A, featuring "S-Vue," an image processing technology that reduces radiation dose by half while producing chest images of comparable quality to conventional X-ray machines. This FDA approval is significant because it acknowledges efforts to reduce radiation dose.

In the research results of Professor Jeong Se-min of Chung-Ang University Hospital, the image quality was evaluated as the same even when the radiation input was reduced by half when shooting with GC85A.

A single chest scan with the Samsung Digital X-ray GC85A exposes patients to an effective dose of 8 microsieverts (μSv) on average.

This is significantly lower than the annual effective dose of 1 millisievert (mSv), which is comparable to the radiation dose from eating about 80 bananas. It's also comparable to the effective dose absorbed by the body during a three-hour flight from New York to Chicago.

“We are pleased to have received FDA approval for our low-dose technology as interest in managing cumulative radiation exposure is growing in each country,” said Song In-sook, Executive Director of Medical Device Product Strategy at Samsung Electronics. “We will continue our efforts to reduce X-ray radiation dose not only for the chest but also for other body parts such as the abdomen, limbs, and even for infants and toddlers.”